News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
The CDC says kids 6 months and older with no underlying health conditions can receive the COVID-19 vaccine in consultation ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
Pediatric and OB-GYN health care providers react to HHS Secretary Robert F. Kennedy Jr’s announcement on COVID-19 vaccine ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback